Supplier News

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

Fujifilm Corporation has announced an initial $10-million investment in a full-scale, fully integrated continuous processing facility for non-GMP manufacturing of biopharmaceuticals at the Billingham, UK site of Fujifilm Diosynth Biotechnologies,...

Aldevron, a contract provider specializing in the production of nucleic acids, proteins, and antibodies, has announced expansion plans for a new 14-acre campus for gene and cell therapy manufacturing at its headquarters in Fargo, North Dakota....

Catalent has announced it is investing up to $40 million at its manufacturing facility in Winchester, Kentucky to increase the site’s formulation and controlled-release tablet and capsule manufacturing capabilities and capacity. New technologies...

The latest news from CDMOs, CMOs, and suppliers featuring news from Vetter, Catalent, Cambrex,  Sharp and Biotechpharma.  Chemicals/Chemical API Manufacturing Cambrex Completes Construction for High-Potency API Facility and QC Lab...

Catalent has agreed to acquire Paragon Bioservices, a Baltimore, Maryland-based contract provider of viral vector development and manufacturing services for gene therapies, for $1.2 billion. Paragon has specialized expertise in adeno-associated...

The latest news from CDMOs, CMOS, and other suppliers featuring news from Wilmington PharmaTech, Insilico, ACG Group, Lonza Chemicals/Chemical API Manufacturing Wilmington PharmaTech To Invest $18 Million In New Research and Mfg Facility...

GE has entered into a definitive agreement to sell its BioPharma business to Danaher Corporation, a global science and technology company, headquartered in Washington D.C., for a total consideration of $21.4 billion, including $21 billion in cash...